Francesco Dal Dosso,
Innovation Manager,
KU Leuven
Dr. Francesco Dal Dosso obtained a MSc. in Biomedical Engineering (Polytechnic of Milan, IT – 2013) and a PhD in Bioscience Engineering (KU Leuven, BE – 2018). Currently, he works as Innovation Manager at the KU Leuven, the most innovative university in Europe (and 7th in the world). As Innovation Manager, FDD is responsible for the exploitation/commercialization of the research done in the IDiaLiST (Integrated Diagnostic and Life Science Research Tools) consortium. In this context, FDD scouts for new exploitation opportunities such as spin-off creation, industrial collaborations, patent applications and licensing. His main research interests involve novel concepts for point-of-care in vitro diagnostics and microsampling exploiting microfluidics technologies. He has been involved in writing and management of >10 (inter)national project funding proposals (KU Leuven, FWO, VLAIO, H2020, H Europe, Bill and Melinda Gates Foundation) as well as bilateral agreement with world-leading diagnostics and pharma companies. He is (co-)author of > 35 peer reviewed research papers and conference contributions (Biosensors, MicroTAS) and inventor of 5 patents.
A Versatile Self-Powered Microfluidic Toolbox: From Sampling to Diagnosis to Therapeutics
Thursday, 10 September 2020 at 09:30
Add to Calendar ▼2020-09-10 09:30:002020-09-10 10:30:00Europe/LondonA Versatile Self-Powered Microfluidic Toolbox: From Sampling to Diagnosis to TherapeuticsPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
At the Biosensors group, we have developed and applied a novel concept to manipulate liquids in a self-powered manner exploiting the advantages of paper- and channel-based microfluidics. This technology, termed (i)SIMPLE, can work both in withdraw and infusion mode being robust, inexpensive, easy to use and fabricate, addressing most of the requirements for a point-of-care (POC) test. Here, we demonstrate the versatility of this platform with 5 different applications: i) an easy to use and inexpensive self-sampling cartridge to precisely meter and dose fingerprick blood droplets into dried blood spots, a gold standard method for remote sample collection, ii) an autonomous on-chip sample preparation device for blood to plasma separation with lab-quality performance, iii) a tunable and precise passive heating unit ideal for an isothermal amplification assay (i.e. RPA) compatible with many lab-on-a-chip approaches, iv) a chip capable of integrating a sandwich ELISA for POC therapeutic drug monitoring of adalimumab in chronic patients affected by autoimmune diseases (i.e. arthritis, Crohn’s) and v) an autonomous and controlled drug/vaccine delivery patch with integrated painless hollow microneedles.
Add to Calendar ▼2020-09-09 00:00:002020-09-10 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2020Point-of-Care, Biosensors and Mobile Diagnostics Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com